Drug Shortage Report for TARO-ZOLEDRONIC ACID

Last updated on 2025-01-21 History
Report ID 166405
Drug Identification Number 02415100
Brand name TARO-ZOLEDRONIC ACID
Common or Proper name ZOLEDRONIC
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) ZOLEDRONIC ACID
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-08-09
Actual start date
Estimated end date
Actual end date 2024-07-01
Shortage status Resolved
Updated date 2025-01-21
Company comments Recall with no back up inventory currently available
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2023-03-24 French Compare
v24 2023-03-24 English Compare
v23 2023-03-10 French Compare
v22 2023-03-10 English Compare
v21 2023-02-01 French Compare
v20 2023-02-01 English Compare
v19 2023-01-20 French Compare
v18 2023-01-20 English Compare
v17 2023-01-10 French Compare
v16 2023-01-10 English Compare
v15 2022-12-12 French Compare
v14 2022-12-12 English Compare
v13 2022-11-24 French Compare
v12 2022-11-24 English Compare
v11 2022-11-15 French Compare
v10 2022-11-15 English Compare
v9 2022-11-03 French Compare
v8 2022-11-03 English Compare
v7 2022-09-16 French Compare
v6 2022-09-16 English Compare

Showing 21 to 40 of 45